Matthew A. Rank

10.1k total citations · 1 hit paper
138 papers, 2.6k citations indexed

About

Matthew A. Rank is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Matthew A. Rank has authored 138 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 48 papers in Pulmonary and Respiratory Medicine and 47 papers in Immunology and Allergy. Recurrent topics in Matthew A. Rank's work include Asthma and respiratory diseases (71 papers), Allergic Rhinitis and Sensitization (41 papers) and Respiratory and Cough-Related Research (30 papers). Matthew A. Rank is often cited by papers focused on Asthma and respiratory diseases (71 papers), Allergic Rhinitis and Sensitization (41 papers) and Respiratory and Cough-Related Research (30 papers). Matthew A. Rank collaborates with scholars based in United States, Canada and Mexico. Matthew A. Rank's co-authors include Hirohito Kita, Diane L. Squillace, Devyani Lal, Kathleen R. Bartemes, Hideaki Kozaki, Takao Kobayashi, Rohit Divekar, Gerald W. Volcheck, Nilay D. Shah and John B. Hagan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Matthew A. Rank

128 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug allergy: A 2022 practice parameter update

2022 246 citations Aleena Banerji, Kimberly G. Blumenthal et al. Journal of Allergy and Clinical Immunology profile →

Peers

Countries citing papers authored by Matthew A. Rank

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Rank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Rank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Rank more than expected).

Fields of papers citing papers by Matthew A. Rank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Rank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Rank. The network helps show where Matthew A. Rank may publish in the future.

Co-authorship network of co-authors of Matthew A. Rank

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Rank. A scholar is included among the top collaborators of Matthew A. Rank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Rank. Matthew A. Rank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Step Down From Scheduled Inhaled Corticosteroids (ICS) Plus As-Needed Fast-Acting Beta-Agonists (FABA) to As-Needed ICS/FABA: A Systematic Review and Meta-Analysis 2025 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), John B. Hagan, (unknown), (unknown), (unknown), Gerald W. Volcheck, Lisa Marks, Derek K. Chu, Matthew A. Rank	0
2	Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics 2024 ·Respiratory Medicine ·Tanawin Nopsopon, (unknown), (unknown), Matthew A. Rank, Krista F. Huybrechts, Ayobami Akenroye	1
3	Predicting Penicillin Allergy: A United States Multicenter Retrospective Study 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Alexei Gonzalez‐Estrada, Miguel A. Park, (unknown), Aleena Banerji, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthew A. Rank, Christine Rukasin, Upeka Samarakoon, Gerald W. Volcheck, Alexander D. Weston, Anna R. Wolfson, Kimberly G. Blumenthal	7
4	KETAMINE-INDUCED PERIOPERATIVE ANAPHYLAXIS: THE IMPORTANCE OF TESTING TO ALL AGENTS REGARDLESS OF THE ANERGIC PERIOD 2024 ·Annals of Allergy Asthma & Immunology ·(unknown), (unknown), Barbara A. Wilson, Matthew A. Rank, Alexei Gonzalez‐Estrada	0
5	Incidence of and risk factors for paediatric perioperative anaphylaxis in the USA 2024 ·British Journal of Anaesthesia ·(unknown), Christine Rukasin, Keith Sacco, Matthew A. Rank, Gerald W. Volcheck, Alexei Gonzalez‐Estrada	1
6	Recent guidelines addressing chronic rhinosinusitis with nasal polyps: practical aspects 2023 ·Polskie Archiwum Medycyny Wewnętrznej ·Matthew A. Rank, (unknown), (unknown)	3
7	Factors Associated with Asthma Biologic Prescribing and Adherence Among Adults in a Large Multi-hospital Health System 2023 ·Journal of Allergy and Clinical Immunology ·Patrick J. Gleeson, Knashawn H. Morales, (unknown), (unknown), Michael O. Harhay, Matthew A. Rank, Andrea Apter, Blanca E. Himes	1
8	Obesity is a risk factor for worse asthma exacerbation outcomes in the United States 2023 ·Journal of Allergy and Clinical Immunology ·Karl T. Mueller, Matthew A. Rank, Alexei Gonzalez‐Estrada, (unknown), Sergio E. Chiarella	0
9	Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice 2023 ·Journal of Allergy and Clinical Immunology ·William E. LeSuer, Melanie Kienzl, Sergei I. Ochkur, Rudolf Schicho, Alfred D. Doyle, Benjamin L. Wright, Matthew A. Rank, Alexander S. Krupnick, Hirohito Kita, Elizabeth A. Jacobsen	35
10	A prediction model for asthma exacerbations after stopping asthma biologics 2022 ·Annals of Allergy Asthma & Immunology ·Jonathan Inselman, Molly M. Jeffery, (unknown), (unknown), Nilay D. Shah, Matthew A. Rank, Che Ngufor	10
11	The chronic rhinosinusitis practice parameter 2022 ·Annals of Allergy Asthma & Immunology ·(unknown), Matthew A. Rank, Anju T. Peters	8
12	Which people with asthma are most likely to be hospitalized with COVID-19 in the United States? 2021 ·The Journal of Allergy and Clinical Immunology In Practice ·Jonathan Inselman, Matthew A. Rank, (unknown), Molly M. Jeffery	5
13	Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies 2021 ·SHILAP Revista de lepidopterología ·John B. Hagan, (unknown), Rohit Divekar, Thanai Pongdee, Matthew A. Rank	2
14	Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy 2020 ·Clinical Gastroenterology and Hepatology ·Benjamin L. Wright, Nielsen Fernandez‐Becker, Neeraja Kambham, Natasha Purington, Shu Cao, Dana Tupa, Wenming Zhang, Sayantani Sindher, Matthew A. Rank, Hirohito Kita, David A. Katzka, Kelly P. Shim, Bryan Bunning, Alfred D. Doyle, Elizabeth A. Jacobsen, Mindy Tsai, Scott D. Boyd, Monali Manohar, R. Sharon Chinthrajah	43
15	Eosinophil-derived IL-13 promotes emphysema 2019 ·European Respiratory Journal ·Alfred D. Doyle, Manali Mukherjee, William E. LeSuer, (unknown), (unknown), Justin J. Frere, (unknown), Jake A. Kloeber, Kelly P. Shim, Sergei I. Ochkur, Terence Ho, Sarah Svenningsen, Benjamin L. Wright, Matthew A. Rank, James J. Lee, Parameswaran Nair, Elizabeth A. Jacobsen	59
16	Trends and Disparities in Asthma Biologic Use in the United States 2019 ·The Journal of Allergy and Clinical Immunology In Practice ·Jonathan Inselman, Molly M. Jeffery, (unknown), Nilay D. Shah, Matthew A. Rank	62
17	Science of Health Care Delivery 2017 ·SHILAP Revista de lepidopterología ·Stephanie R. Starr, Neera Agrwal, Michael Bryan, (unknown), Jack A. Gilbert, Jill M. Huber, Andrea N. Leep Hunderfund, Mark Liebow, (unknown), Neena Natt, Ashokakumar M. Patel, Bhavesh Patel, Kenneth Poole, Matthew A. Rank, (unknown), Amit Shah, Natalia Wilson, (unknown)	16
18	Adherence to Topical Medications for Chronic Rhinosinusitis: Medication Posession Ratio and Description of Adherence Barriers 2016 ·Journal of Allergy and Clinical Immunology ·(unknown), Devyani Lal, Matthew A. Rank, John C. Lewis, (unknown)	1
19	Obesity, low levels of physical activity and smoking present opportunities for primary care asthma interventions: an analysis of baseline data from The Asthma Tools Study 2015 ·npj Primary Care Respiratory Medicine ·Barbara P. Yawn, Matthew A. Rank, Susan Bertram, Peter C. Wollan	27
20	Long-term Safety of Nebulized Lidocaine for Adults With Difficult-to-Control Chronic Cough 2012 ·CHEST Journal ·Kaiser G. Lim, Matthew A. Rank, Peter Y. Hahn, Karina A. Keogh, Timothy I. Morgenthaler, Eric J. Olson	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact